Clinical Trial Update: CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS) [Phase 4]

View source ↗

Summary

A Phase 4 post-marketing surveillance registry for the Cypher Stent in the US has completed enrollment, collecting real-world data on coronary artery disease pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher Stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED